about
Leptin-Induced JAK/STAT Signaling and Cancer GrowthEffects of Brassicaceae Isothiocyanates on Prostate CancerRegulation of STATs by polycystin-1 and their role in polycystic kidney diseaseOncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cellsTargeting the innate immune system as immunotherapy for acute myeloid leukemiaPathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus ErythematosusScoparone exerts anti-tumor activity against DU145 prostate cancer cells via inhibition of STAT3 activityThe clinicopathological significance of NAB2-STAT6 gene fusions in 52 cases of intrathoracic solitary fibrous tumorsAlteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy.Leptin signaling molecular actions and drug target in hepatocellular carcinomaDevelopment of new N-Arylbenzamides as STAT3 Dimerization Inhibitors.Scoparone interferes with STAT3-induced proliferation of vascular smooth muscle cells.LPA Induces Colon Cancer Cell Proliferation through a Cooperation between the ROCK and STAT-3 Pathways.Heteronemin Is a Novel c-Met/STAT3 Inhibitor Against Advanced Prostate Cancer Cells.Role of STAT3 in lung cancer.Withaferin-A Inhibits Colon Cancer Cell Growth by Blocking STAT3 Transcriptional ActivitySTAT3 Signaling in Polycystic Kidney DiseaseMelittin derived peptides for nanoparticle based siRNA transfection.Fragment-based drug design and identification of HJC0123, a novel orally bioavailable STAT3 inhibitor for cancer therapy.STAT3: the "Achilles" heel for AML?An inhibitor of cholesterol absorption displays anti-myeloma activity by targeting the JAK2-STAT3 signaling pathwayRosmarinic acid suppresses colonic inflammation in dextran sulphate sodium (DSS)-induced mice via dual inhibition of NF-κB and STAT3 activation.Translation of molecular pathways into clinical trials of neuroendocrine tumors.The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer.Oncogenic role and therapeutic target of leptin signaling in colorectal cancer.Methanethiosulfonate derivatives as ligands of the STAT3-SH2 domain.Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment.Presence and utility of intrinsically disordered regions in kinases.Off-target effects of plasmid-transcribed shRNAs on NFκB signaling pathway and cell survival of human melanoma cells.A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells.Cardamonin represses proliferation, invasion, and causes apoptosis through the modulation of signal transducer and activator of transcription 3 pathway in prostate cancer.An SH2 domain model of STAT5 in complex with phospho-peptides define "STAT5 Binding Signatures".The STAT3 inhibitor pimozide impedes cell proliferation and induces ROS generation in human osteosarcoma by suppressing catalase expressionHydroxyflavanone inhibits gastric carcinoma MGC-803 cell proliferation.Hepatitis C virus core protein regulates NANOG expression via the stat3 pathway.Low-dose Erythropoietin reduces risk of heart failure induced by anti-cancer therapy.Naphthoquinones: A continuing source for discovery of therapeutic antineoplastic agents.Nitidine chloride acts as an apoptosis inducer in human oral cancer cells and a nude mouse xenograft model via inhibition of STAT3.Lycorine inhibits the growth and metastasis of breast cancer through the blockage of STAT3 signaling pathway.Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic.
P2860
Q26740512-CC6A6FBE-80D9-47E4-B91D-EBFA16DD39F0Q26749086-F3196A8A-42B5-4004-9304-7D23E04598BFQ26852136-8BC53BD7-1A68-4B8F-A99B-D8516A66C111Q26861403-E977F322-314C-46CA-B66B-663685266828Q27015876-BD8021E0-BAE6-483E-A5DF-2F6937C6837CQ28088753-292D12C9-A1DF-4F9F-AA48-DDA23C899037Q28535173-A53FBA89-A3BE-4B1D-9B57-CC47D0E94190Q33428552-38AC8985-E26C-4AE4-9D2A-1CA76F5255AEQ33838824-0D973E99-7F0C-47AA-BF85-88A2E31EFBA1Q34548342-212E37AF-AE87-46C6-97EC-90884154CA47Q35000997-26D869D8-98EA-4558-B90D-85FF7C4B9D5DQ35152938-11F0467C-F342-4B09-A6DA-8C2511580DA9Q35791590-70EC91EE-DB11-4844-876D-FE7FABE17F7BQ36077939-61EE65C4-062E-4ED3-B96F-9BB85F9047BEQ36086059-1B9577AA-CF69-4537-8C20-F37C718F29C8Q36135798-64169FD3-1A6B-4FEF-8C8E-7055AFBD68E4Q36218762-3ED0890E-E21B-4CDA-A47B-3F039CE13A4DQ36626455-E2EC9460-C7C2-4628-B1CC-79238891231AQ37113973-F93154AB-819A-4ADA-9C2D-24A098DC7E1AQ37429669-D5C798F4-C19E-41CE-8DC4-F63777BA2CCDQ37688978-269ED7B5-8767-4256-BFE1-D0004642922CQ37739694-69DEF674-516D-48B3-A323-2D7D8043F2E4Q38003074-0A7F003A-9347-4186-87DD-BF1CCB389CD3Q38203779-E259BBC6-4C26-422C-B8E4-CC4699622410Q38221662-031046B1-81EF-46B1-B1C0-0A2B5A147C03Q38720827-232F7E78-7ED4-44D2-A789-A14FBF4EDE91Q38925157-0AF98CE6-3FBE-424E-957D-88EF9D4150A3Q38968261-5F1B9F3C-F892-4B97-84F7-CB27BD536948Q39068964-C78CE826-5A27-4535-AE02-07D90423311EQ39121242-CCF207BF-298F-469A-AFD1-D206BCA12C69Q39143805-AF0F4F74-A33C-4480-9D9F-628A9AE41425Q41264901-69784DA6-F4C6-4BC3-959B-A731E2CB74F6Q41549450-51AA870F-5D79-432A-A2D5-BDA791E372C5Q41881280-C4DD7614-9DEC-448E-BAC0-78C39F499491Q42241285-DFA98529-DFCD-4F37-BFE9-89D62D6B44C7Q43057173-7A7295E6-F90C-403D-B25F-B36049B41204Q46262914-53A71534-D322-4850-B33F-2585E0D052E4Q47160725-EA28E6E6-98BF-4058-8D0B-6CA7316B6AC2Q50089117-A1DFC1EA-C01E-48A2-BD94-4FD4680D7A7CQ51825149-FCA29271-937F-4EC1-9DD1-78CBF1854B4B
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Small molecule inhibitors of STAT3 for cancer therapy.
@ast
Small molecule inhibitors of STAT3 for cancer therapy.
@en
type
label
Small molecule inhibitors of STAT3 for cancer therapy.
@ast
Small molecule inhibitors of STAT3 for cancer therapy.
@en
prefLabel
Small molecule inhibitors of STAT3 for cancer therapy.
@ast
Small molecule inhibitors of STAT3 for cancer therapy.
@en
P2093
P1476
Small molecule inhibitors of STAT3 for cancer therapy.
@en
P2093
P304
P356
10.2174/092986711796957284
P577
2011-01-01T00:00:00Z